4.7 Article

IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation

期刊

STEM CELLS
卷 31, 期 10, 页码 2193-2204

出版社

WILEY-BLACKWELL
DOI: 10.1002/stem.1463

关键词

Mouse; Osteoblasts; Niche; Insulin-like growth factor 1; Stem cell transplantation

资金

  1. NIH [R01 HL077643, T32HL007150-34]
  2. NHLBI [2 K12 HL087064]
  3. Canuso Foundation Innovation Grant
  4. Ministero della Salute Bando Cellule Staminali
  5. Regione Emilia Romagna
  6. Associazione per il Sostegno dell'Ematologia e dell'Oncologia Pediatrica (ASEOP)
  7. Fondazione Cassa di Risparmio di Modena

向作者/读者索取更多资源

The efficiency of hematopoietic stem cell (HSC) engraftment after bone marrow (BM) transplantation depends largely on the capacity of the marrow microenvironment to accept the transplanted cells. While radioablation of BM damages osteoblastic stem cell niches, little is known about their restoration and mechanisms governing their receptivity to engraft transplanted HSCs. We previously reported rapid restoration and profound expansion of the marrow endosteal microenvironment in response to marrow radioablation. Here, we show that this reorganization represents proliferation of mature endosteal osteoblasts which seem to arise from a small subset of high-proliferative, relatively radio-resistant endosteal cells. Multiple layers of osteoblasts form along the endosteal surface within 48 hours after total body irradiation, concomitant with a peak in marrow cytokine expression. This niche reorganization fosters homing of the transplanted hematopoietic cells to the host marrow space and engraftment of long-term-HSC. Inhibition of insulin-like growth factor (IGF)-1-receptor tyrosine kinase signaling abrogates endosteal osteoblast proliferation and donor HSC engraftment, suggesting that the cytokine IGF-1 is a crucial mediator of endosteal niche reorganization and consequently donor HSC engraftment. Further understanding of this novel mechanism of IGF-1-dependent osteoblastic niche expansion and HSC engraftment may yield clinical applications for improving engraftment efficiency after clinical HSC transplantation. Stem Cells 2013;31:2193-2204

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients

Silvia Belluti, Valentina Semeghini, Giovanna Rigillo, Mirko Ronzio, Daniela Benati, Federica Torricelli, Luca Reggiani Bonetti, Gianluca Carnevale, Giulia Grisendi, Alessia Ciarrocchi, Massimo Dominici, Alessandra Recchia, Diletta Dolfini, Carol Imbriano

Summary: The regulation of NF-YA isoforms plays a crucial role in the progression and aggressiveness of prostate cancer, with elevated levels of NF-YAs associated with malignancy. NF-YAI overexpression increases cell motility, while NF-YAs enhances cell proliferation. The transcriptome of NF-YAs-spheroids shows extensive overlap with localized and metastatic prostate cancer profiles.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma

Giulia Golinelli, Giulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, Carlotta Spano, Rebecca Talami, Federico Banchelli, Malvina Prapa, Chiara Chiavelli, Filippo Rossignoli, Olivia Candini, Roberto D'Amico, Milena Nasi, Andrea Cossarizza, Livio Casarini, Massimo Dominici

Summary: The study demonstrates that bi-functional MSCs expressing TRAIL and GD2 tCAR can effectively target and kill ES tumor cells, showing good efficacy in targeting and eliminating ES in the lungs but not in the liver.

TRANSLATIONAL ONCOLOGY (2022)

Article Cell & Tissue Engineering

The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study

Valentina Masciale, Federico Banchelli, Giulia Grisendi, Roberto D'Amico, Antonino Maiorana, Alessandro Stefani, Uliano Morandi, Franco Stella, Massimo Dominici, Beatrice Aramini

Summary: This study assessed the relationship between cancer stem cells (CSCs) and relapse rates in patients with adenocarcinoma (ADL) and squamous cell carcinoma of the lung (SCCL). The results showed no association between CSCs and relapse rates in early-stage patients, but a positive correlation was observed in locally advanced patients.

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Article Oncology

The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma

Sofia Avnet, Silvia Lemma, Margherita Cortini, Gemma Di Pompo, Francesca Perut, Maria Veronica Lipreri, Laura Roncuzzi, Marta Columbaro, Costantino Errani, Alessandra Longhi, Nicoletta Zini, Dominique Heymann, Massimo Dominici, Giulia Grisendi, Giulia Golinelli, Lorena Consolino, Dario Livio Longo, Cristina Nanni, Alberto Righi, Nicola Baldini

Summary: The study validated the correlation between tumor glycolysis/acidosis and metastasis, and investigated the role of acidity-induced inflammation in the development of metastasis in osteosarcoma.

CANCERS (2021)

Review Oncology

Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence

Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Federica Bertolini, Michela Maur, Giorgia Guaitoli, Isca Chrystel, Uliano Morandi, Franco Stella, Massimo Dominici, Khawaja Husnain Haider

Summary: Cancer stem cells (CSCs) play a crucial role in tumor initiation, progression, and metastasis. They share characteristics with normal stem cells, such as self-renewal and differentiation potential. CSCs establish their niche, a unique microenvironment within the tissue, which sustains their functions. The interactions between CSCs and their niches regulate their self-renewal and tumorigenesis. Understanding the primary mechanisms involved in CSC tumorigenesis is essential for developing targeted therapies. Moreover, CSCs' resistance to standard treatments and their phenotypic plasticity pose challenges in cancer therapeutics.

CANCERS (2022)

Article Cell Biology

A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors

Giulia Golinelli, Rebecca Talami, Stella Frabetti, Olivia Candini, Giulia Grisendi, Carlotta Spano, Chiara Chiavelli, Gaelle F. Arnaud, Giorgio Mari, Massimo Dominici

Summary: In this study, the dynamic cell-to-cell interactions between tumor and MSCs were investigated using a customized VITVO50 3D bioreactor. The process of tissue colonization and formation of metastatic nodules was recreated under dynamic conditions. The results showed that VITVO50 is an easy handling and versatile bioreactor for developing in vivo-like tumor nodules and investigating dynamic cell-to-cell interactions with MSCs.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Cell & Tissue Engineering

Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study

Valentina Masciale, Federico Banchelli, Giulia Grisendi, Roberto D'Amico, Antonino Maiorana, Alessandro Stefani, Uliano Morandi, Franco Stella, Massimo Dominici, Beatrice Aramini

Summary: This study found that the frequency of cancer stem cells (CSCs) and the expression of recurrence-related genes (RG) are independent predictors of disease-free survival in lung cancer. The frequency of CSCs is not related to disease-free survival in early-stage patients, but is a risk factor for locally advanced-stage patients. Moreover, measuring the expression of RG in CSCs is associated with a higher risk of recurrence. These findings suggest that CSCs and RG may have implications for targeted therapy and prognosis in lung cancer.

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Article Biology

Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres

Paolo Cameli, Paola Faverio, Katia Ferrari, Viola Bonti, Stefania Marsili, Maria Antonietta Mazzei, Francesca Mazzoni, Maurizio Bartolucci, Vieri Scotti, Federica Bertolini, Fausto Barbieri, Cinzia Baldessari, Chiara Veronese, Roberto Boffi, Matteo Brighenti, Diego Cortinovis, Massimo Dominici, Alberto Pesci, Elena Bargagli, Fabrizio Luppi

Summary: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but can lead to immune-related adverse events, including lung toxicity. This study describes the clinical, radiological features, and survival of patients with ICI-related lung toxicity. The results showed that the latency of toxicity was not limited to the first year of treatment, emphasizing the importance of long-term follow-up for early diagnosis and appropriate management.

LIFE-BASEL (2022)

Article Cell Biology

Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance

Maria Serena Piccinno, Tiziana Petrachi, Marco Pignatti, Alba Murgia, Giulia Grisendi, Olivia Candini, Elisa Resca, Valentina Bergamini, Francesco Ganzerli, Alberto Portone, Ilenia Mastrolia, Chiara Chiavelli, Ilaria Castelli, Daniela Bernabei, Mara Tagliazucchi, Elisa Bonetti, Francesca Lolli, Giorgio De Santis, Massimo Dominici, Elena Veronesi

Summary: This study investigates the use of adipose-derived mesenchymal stromal/stem cells (AD-MSCs) in autologous fat transfer (AFT) for tissue reconstruction. The results show that AD-MSCs can improve graft persistence and reduce tissue resorption after AFT. The implanted AD-MSCs can persist and differentiate into mature adipocytes, leading to better outcomes in terms of graft weight and reduced cyst formation. This suggests a long-term protective and anti-inflammatory/proangiogenic role of AD-MSCs in autologous AFT tissue resorption.
Article Pharmacology & Pharmacy

Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis

Ilenia Mastrolia, Andrea Giorgini, Alba Murgia, Pietro Loschi, Tiziana Petrachi, Valeria Rasini, Massimo Pinelli, Valentina Pinto, Francesca Lolli, Chiara Chiavelli, Giulia Grisendi, Maria Cristina Baschieri, Giorgio De Santis, Fabio Catani, Massimo Dominici, Elena Veronesi

Summary: In this study, a rabbit model was established to mimic human osteonecrosis of the femoral head (ONFH) and evaluate the autologous MSC-based treatment. Results showed that implantation of autologous BM-MSCs could restore the damaged tissue in rabbit femurs. Furthermore, the study found that osteonecrosis did not affect the behavior of MSCs.

PHARMACEUTICS (2022)

Article Cell Biology

Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer

Elisa Pardella, Erica Pranzini, Ilaria Nesi, Matteo Parri, Pietro Spatafora, Eugenio Torre, Angela Muccilli, Francesca Castiglione, Massimiliano Fambrini, Flavia Sorbi, Paolo Cirri, Anna Caselli, Martin Puhr, Helmut Klocker, Sergio Serni, Giovanni Raugei, Francesca Magherini, Maria Letizia Taddei

Summary: Cancer progression is supported by the interaction between tumor cells and the surrounding stroma. Chemotherapy-induced senescence in both tumor and non-cancerous cells contributes to the adverse effects of therapies. It has been found that chemotherapy drugs promote senescence in stromal fibroblasts, leading to metabolic alterations and secretion of paracrine factors, thereby enhancing the invasive and clonogenic potential of prostate and ovarian cancer cells. Clearance of senescent stromal cells can reverse the malignant phenotype of tumor cells. This has important implications for combining traditional anticancer strategies with innovative senotherapy to enhance anticancer treatments and overcome the adverse effects of chemotherapy.
Article Oncology

Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model

Elisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, Margherita Mirabile, Francesca Pedrazzi, Elena Genovese, Stefano Sartini, Massimiliano Dall'Ora, Giulia Grisendi, Luca Fabbiani, Monica Maccaferri, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Niccolo Bartalucci, Laura Calabresi, Manjola Balliu, Paola Guglielmelli, Leonardo Potenza, Enrico Tagliafico, Lorena Losi, Massimo Dominici, Mario Luppi, Alessandro Maria Vannucchi, Rossella Manfredini

Summary: BM fibrosis is a major pathology in myelofibrosis and is associated with overexpression of OPN protein. ERK1/2 is a key regulator of OPN production, and inhibiting ERK1/2 activity can reduce OPN production and hinder the development of BM fibrosis. Targeting OPN and ERK1/2 could be potential therapeutic strategies for myelofibrosis.

LEUKEMIA (2023)

Review Oncology

De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?

Claudia Piombino, Marco Oltrecolli, Elena Tonni, Marta Pirola, Rossana Matranga, Cinza Baldessari, Stefania Pipitone, Massimo Dominici, Roberto Sabbatini, Maria Giuseppa Vitale

Summary: De novo metastatic hormone-sensitive prostate cancer usually has a poor prognosis, but recent advancements in new hormonal agents and combination therapy have slightly improved outcomes. Ongoing clinical trials are exploring new therapeutic approaches and personalized treatment options based on genomic features and biomarker-guided treatment.

CANCERS (2023)

Meeting Abstract Biotechnology & Applied Microbiology

CRISPR-Mediated T Cell Engineering Against Non-Small Cell Lung Cancer

Daniela Benati, Tommaso Ferrari, Valentina Masciale, Giulia Grisendi, Beatrice Aramini, Uliano Morandi, Antonino Maiorana, Massimo Dominici, Alessandra Recchia

MOLECULAR THERAPY (2022)

Meeting Abstract Cell & Tissue Engineering

AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA

C. Chiavelli, M. Prapa, G. Neri, G. Pugliese, G. Rovesti, L. Trudu, G. Grisendi, M. dall'ora, G. Golinelli, M. Bestagno, O. Candini, C. Spano, R. Di Tinco, L. Bertoni, G. Carnevale, R. Papapietro, R. Depenni, A. Feletti, C. Iaccarino, G. Pavesi, M. Dominici

CYTOTHERAPY (2022)

暂无数据